123 related articles for article (PubMed ID: 9291341)
1. High-dose interferon-alpha2a exerts potent activity against human immunodeficiency virus type 1 not associated with antitumor activity in subjects with Kaposi's sarcoma.
Frissen PH; de Wolf F; Reiss P; Bakker PJ; Veenhof CH; Danner SA; Goudsmit J; Lange JM
J Infect Dis; 1997 Sep; 176(3):811-4. PubMed ID: 9291341
[TBL] [Abstract][Full Text] [Related]
2. Long-term efficacy on Kaposi's sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients. CISIH 92. Centre d'information et de soins de l'immunodéficience humaine.
Dupont C; Vasseur E; Beauchet A; Aegerter P; Berthé H; de Truchis P; Zucman D; Rouveix E; Saiag P
AIDS; 2000 May; 14(8):987-93. PubMed ID: 10853980
[TBL] [Abstract][Full Text] [Related]
3. Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy.
Cattelan AM; Calabrò ML; De Rossi A; Aversa SM; Barbierato M; Trevenzoli M; Gasperini P; Zanchetta M; Cadrobbi P; Monfardini S; Chieco-Bianchi L
Int J Oncol; 2005 Sep; 27(3):779-85. PubMed ID: 16077928
[TBL] [Abstract][Full Text] [Related]
4. Prospective randomized trial of two dose levels of interferon alfa with zidovudine for the treatment of Kaposi's sarcoma associated with human immunodeficiency virus infection: a Canadian HIV Clinical Trials Network study.
Shepherd FA; Beaulieu R; Gelmon K; Thuot CA; Sawka C; Read S; Singer J
J Clin Oncol; 1998 May; 16(5):1736-42. PubMed ID: 9586886
[TBL] [Abstract][Full Text] [Related]
5. Detection of Kaposi's sarcoma-associated herpesvirus in peripheral blood cells in human immunodeficiency virus infection: association with Kaposi's sarcoma, CD4 cell count, and HIV RNA levels.
Min J; Katzenstein DA
AIDS Res Hum Retroviruses; 1999 Jan; 15(1):51-5. PubMed ID: 10024052
[TBL] [Abstract][Full Text] [Related]
6. Therapy of special HIV-associated diseases: HCV-HIV-co-infection and AIDS-related Kaposi's sarcoma - official satellite to the 7th European Conference on Clinical Aspects and Treatment of HIV-infection, October 23, 1999 in Lisbon, Portugal.
Goebel FD; Jablonowski H
Eur J Med Res; 1999 Dec; 4(12):507-13. PubMed ID: 10611054
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of low-dose interferon with antiretroviral therapy in Kaposi's sarcoma: a randomized phase II AIDS clinical trials group study.
Krown SE; Li P; Von Roenn JH; Paredes J; Huang J; Testa MA
J Interferon Cytokine Res; 2002 Mar; 22(3):295-303. PubMed ID: 12034036
[TBL] [Abstract][Full Text] [Related]
8. Open-label phase I study of combination therapy with zidovudine and interferon-beta in patients with AIDS-related Kaposi's sarcoma: AIDS Clinical Trials Group Protocol 057.
Miles S; Levine A; Feldstein M; Carden J; Cabriallas S; Marcus S; Mitsuyasu R; Gill P
Cytokines Cell Mol Ther; 1998 Mar; 4(1):17-23. PubMed ID: 9557213
[TBL] [Abstract][Full Text] [Related]
9. Interferon-alpha2b with protease inhibitor-based antiretroviral therapy in patients with AIDS-associated Kaposi sarcoma: an AIDS malignancy consortium phase I trial.
Krown SE; Lee JY; Lin L; Fischl MA; Ambinder R; Von Roenn JH
J Acquir Immune Defic Syndr; 2006 Feb; 41(2):149-53. PubMed ID: 16394845
[TBL] [Abstract][Full Text] [Related]
10. Monitoring of endogenous interferon-alpha and human herpesvirus 8 in HIV-infected patients with Kaposi's sarcoma.
Plettenberg A; Albrecht D; Lorenzen T; Meyer T; Arndt R; Stoehr A
Eur J Med Res; 2002 Jan; 7(1):19-24. PubMed ID: 11827836
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial of interferon-alpha2a and zidovudine versus bleomycin and zidovudine for AIDS-related Kaposi's sarcoma. Swiss HIV Cohort Study.
Opravil M; Hirschel B; Bucher HC; Lüthy R
Int J STD AIDS; 1999 Jun; 10(6):369-75. PubMed ID: 10414879
[TBL] [Abstract][Full Text] [Related]
12. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
13. Effects of interferon-alpha in patients with AIDS-associated Kaposi's sarcoma are related to blood interferon levels and dose.
Sawyer LA; Metcalf JA; Zoon KC; Boone EJ; Kovacs JA; Lane HC; Quinnan GV
Cytokine; 1990 Jul; 2(4):247-52. PubMed ID: 2104226
[TBL] [Abstract][Full Text] [Related]
14. AIDS-related Kaposi's sarcoma patients with visceral manifestations. Response to human chorionic gonadotropin preparations.
Hermans P; Clumeck N; Picard O; van Vooren JP; Duriez P; Zucman D; Bryant JL; Gill P; Lunardi-Iskandar Y; Gallo RC
J Hum Virol; 1998; 1(2):82-9. PubMed ID: 10195236
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic response of HIV-1 subtype C in African patients coinfected with either Mycobacterium tuberculosis or human herpesvirus-8.
Cassol E; Page T; Mosam A; Friedland G; Jack C; Lalloo U; Kopetka J; Patterson B; Esterhuizen T; Coovadia HM
J Infect Dis; 2005 Feb; 191(3):324-32. PubMed ID: 15633090
[TBL] [Abstract][Full Text] [Related]
16. Relationship of vitamin D insufficiency to AIDS-associated Kaposi's sarcoma outcomes: retrospective analysis of a prospective clinical trial in Zimbabwe.
Erlandson KM; Gudza I; Fiorillo S; Ndemera B; Schooley RT; Gwanzura L; Borok M; Campbell TB
Int J Infect Dis; 2014 Jul; 24():6-10. PubMed ID: 24769175
[TBL] [Abstract][Full Text] [Related]
17. Treatment of AIDS-related Kaposi's sarcoma with interleukin-12: rationale and preliminary evidence of clinical activity.
Yarchoan R; Pluda JM; Wyvill KM; Aleman K; Rodriguez-Chavez IR; Tosato G; Catanzaro AT; Steinberg SM; Little RF
Crit Rev Immunol; 2007; 27(5):401-14. PubMed ID: 18197804
[TBL] [Abstract][Full Text] [Related]
18. Lack of antitumor activity and intolerance of interleukin-4 in patients with advanced HIV disease and Kaposi's sarcoma.
Miles SA; Testa M; Huang J; Wade M; Carden J; Scadden DT
J Interferon Cytokine Res; 2002 Nov; 22(11):1143-8. PubMed ID: 12513914
[TBL] [Abstract][Full Text] [Related]
19. Enhanced in vivo human immunodeficiency virus-1 replication in the lungs of human immunodeficiency virus-infected persons with Pneumocystis carinii pneumonia.
Koziel H; Kim S; Reardon C; Li X; Garland R; Pinkston P; Kornfeld H
Am J Respir Crit Care Med; 1999 Dec; 160(6):2048-55. PubMed ID: 10588627
[TBL] [Abstract][Full Text] [Related]
20. Safety and antiviral activity of combination therapy with zidovudine, zalcitabine, and two doses of interferon-alpha2a in patients with HIV. AIDS Clinical Trials Group Study 197.
Fischl MA; Richman DD; Saag M; Meng TC; Squires KE; Holden-Wiltse J; Meehan PM
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Dec; 16(4):247-53. PubMed ID: 9402071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]